Mirati Therapeutics, Inc.
Records under this name other than the patents Mirati Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 40 patents it holds.
Back to Mirati Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,125,134 | Kras G12C Inhibitors now held by Array Biopharma Inc. In force · High confidence | In force | High confidence | |
| US 10,647,715 | Kras G12C Inhibitors now held by Array Biopharma Inc. In force · High confidence | In force | High confidence | |
| US 10,689,377 | Kras G12C Inhibitors now held by Array Biopharma Inc. In force · High confidence | In force | High confidence | |
| US 11,267,812 | Kras G12C Inhibitors now held by Array Biopharma Inc. In force · High confidence | In force | High confidence | |
| US 11,548,888 | Kras G12C Inhibitors now held by Array Biopharma Inc. In force · High confidence | In force | High confidence | |
| US 11,964,989 | Kras G12D Inhibitors now held by Array Biopharma Inc. In force · High confidence | In force | High confidence | |
| US 12,630,566 | Kras G12D Inhibitors now held by Array Biopharma Inc. In force · High confidence | In force | High confidence | |
| US 12,747,253 | Kras G12D Inhibitors now held by Array Biopharma Inc. In force · Medium confidence | In force | Medium confidence | |
| US 11,453,683 | Kras G12D Inhibitors now held by Array Biopharma Inc. In force · High confidence | In force | High confidence | |
| US 11,932,633 | Kras G12C Inhibitors now held by Array Biopharma Inc. In force · High confidence | In force | High confidence |